mct ro3306 group (MedChemExpress)
MedChemExpress is a verified supplier 
MedChemExpress manufactures this product 
97
Structured Review
MedChemExpress
mct ro3306 group
Mct Ro3306 Group, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 97/100, based on 112 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mct+ro3306+group/Ro-3306/pm41612370-90-170-184
Average 97 stars, based on 112 article reviews
Mct Ro3306 Group, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 97/100, based on 112 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mct+ro3306+group/Ro-3306/pm41612370-90-170-184
Average 97 stars, based on 112 article reviews
mct ro3306 group - by Bioz Stars,
2026-09
97/100 stars
Images
Related Articles
Control:Article Title: Activation of PBK by Gal-3 contributes to pulmonary artery hypertension by promoting PRC1 activation. Article Snippet: .. AR TIC LE IN PR ES S ARTICLE IN PRESS Control group: administered intraperitoneal vehicle solution (60 mg/kg) on day 1, intraperitoneal injection of saline for 28 days; MCT group: administered intraperitoneal monocrotaline (MCT) (60 mg/kg, Must Bio-Technology, China) on day 1; MCT + DMSO group: administered 28 days of DMSO intraperitoneal injection after MCT administration on day 1; MCT + MCP group: received 28 days of Gal3 inhibitor PectaSol modified citrus pectin (MCP) (100 mg/kg/d, orally, Econugenics, Santa Rosa, CA, USA) after MCT administration (36); MCT + TAK-242 group: received TLR4 receptor inhibitor TAK242 (3 mg/kg/d, intraperitoneal injection, Aladdin, T125887) for 28 days after MCT administration (37); MCT + VP group: received YAP1 inhibitor verteporfin (VP) (4.5 mg/kg, every 2 days, intraperitoneal injection, Aladdin, V129759) for 28 days after MCT administration (38); MCT + NC siRNA group: received NC siRNA (0.2 mg/kg/w tailvein injection, GenePharma, China) for 28 days after MCT administration; MCT + PLK1 siRNA-targeted group: received PLK1 siRNA molecule for 28 days after the injection of MCT; Injection:Article Title: Activation of PBK by Gal-3 contributes to pulmonary artery hypertension by promoting PRC1 activation. Article Snippet: .. AR TIC LE IN PR ES S ARTICLE IN PRESS Control group: administered intraperitoneal vehicle solution (60 mg/kg) on day 1, intraperitoneal injection of saline for 28 days; MCT group: administered intraperitoneal monocrotaline (MCT) (60 mg/kg, Must Bio-Technology, China) on day 1; MCT + DMSO group: administered 28 days of DMSO intraperitoneal injection after MCT administration on day 1; MCT + MCP group: received 28 days of Gal3 inhibitor PectaSol modified citrus pectin (MCP) (100 mg/kg/d, orally, Econugenics, Santa Rosa, CA, USA) after MCT administration (36); MCT + TAK-242 group: received TLR4 receptor inhibitor TAK242 (3 mg/kg/d, intraperitoneal injection, Aladdin, T125887) for 28 days after MCT administration (37); MCT + VP group: received YAP1 inhibitor verteporfin (VP) (4.5 mg/kg, every 2 days, intraperitoneal injection, Aladdin, V129759) for 28 days after MCT administration (38); MCT + NC siRNA group: received NC siRNA (0.2 mg/kg/w tailvein injection, GenePharma, China) for 28 days after MCT administration; MCT + PLK1 siRNA-targeted group: received PLK1 siRNA molecule for 28 days after the injection of MCT; Saline:Article Title: Activation of PBK by Gal-3 contributes to pulmonary artery hypertension by promoting PRC1 activation. Article Snippet: .. AR TIC LE IN PR ES S ARTICLE IN PRESS Control group: administered intraperitoneal vehicle solution (60 mg/kg) on day 1, intraperitoneal injection of saline for 28 days; MCT group: administered intraperitoneal monocrotaline (MCT) (60 mg/kg, Must Bio-Technology, China) on day 1; MCT + DMSO group: administered 28 days of DMSO intraperitoneal injection after MCT administration on day 1; MCT + MCP group: received 28 days of Gal3 inhibitor PectaSol modified citrus pectin (MCP) (100 mg/kg/d, orally, Econugenics, Santa Rosa, CA, USA) after MCT administration (36); MCT + TAK-242 group: received TLR4 receptor inhibitor TAK242 (3 mg/kg/d, intraperitoneal injection, Aladdin, T125887) for 28 days after MCT administration (37); MCT + VP group: received YAP1 inhibitor verteporfin (VP) (4.5 mg/kg, every 2 days, intraperitoneal injection, Aladdin, V129759) for 28 days after MCT administration (38); MCT + NC siRNA group: received NC siRNA (0.2 mg/kg/w tailvein injection, GenePharma, China) for 28 days after MCT administration; MCT + PLK1 siRNA-targeted group: received PLK1 siRNA molecule for 28 days after the injection of MCT; Modification:Article Title: Activation of PBK by Gal-3 contributes to pulmonary artery hypertension by promoting PRC1 activation. Article Snippet: .. AR TIC LE IN PR ES S ARTICLE IN PRESS Control group: administered intraperitoneal vehicle solution (60 mg/kg) on day 1, intraperitoneal injection of saline for 28 days; MCT group: administered intraperitoneal monocrotaline (MCT) (60 mg/kg, Must Bio-Technology, China) on day 1; MCT + DMSO group: administered 28 days of DMSO intraperitoneal injection after MCT administration on day 1; MCT + MCP group: received 28 days of Gal3 inhibitor PectaSol modified citrus pectin (MCP) (100 mg/kg/d, orally, Econugenics, Santa Rosa, CA, USA) after MCT administration (36); MCT + TAK-242 group: received TLR4 receptor inhibitor TAK242 (3 mg/kg/d, intraperitoneal injection, Aladdin, T125887) for 28 days after MCT administration (37); MCT + VP group: received YAP1 inhibitor verteporfin (VP) (4.5 mg/kg, every 2 days, intraperitoneal injection, Aladdin, V129759) for 28 days after MCT administration (38); MCT + NC siRNA group: received NC siRNA (0.2 mg/kg/w tailvein injection, GenePharma, China) for 28 days after MCT administration; MCT + PLK1 siRNA-targeted group: received PLK1 siRNA molecule for 28 days after the injection of MCT; |